Jefferies Financial Group Inc. Trims Stock Holdings in iShares Biotechnology ETF $IBB

Jefferies Financial Group Inc. reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 33.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 300,458 shares of the financial services provider’s stock after selling 150,349 shares during the quarter. Jefferies Financial Group Inc. owned about 0.61% of iShares Biotechnology ETF worth $50,708,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC purchased a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at $201,000. AQR Capital Management LLC purchased a new position in iShares Biotechnology ETF in the first quarter worth $455,000. Millennium Management LLC grew its holdings in iShares Biotechnology ETF by 140.8% in the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after purchasing an additional 143,893 shares during the last quarter. M&T Bank Corp grew its holdings in iShares Biotechnology ETF by 39.3% in the second quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock worth $337,000 after purchasing an additional 750 shares during the last quarter. Finally, Walleye Capital LLC grew its holdings in iShares Biotechnology ETF by 26.8% in the second quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock worth $589,000 after purchasing an additional 985 shares during the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 0.2%

NASDAQ IBB opened at $168.79 on Friday. iShares Biotechnology ETF has a 12-month low of $119.78 and a 12-month high of $179.64. The firm’s fifty day simple moving average is $168.91 and its two-hundred day simple moving average is $169.89.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were given a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.